Ianalumab
id:
ianalumab-198-324496
title:
Ianalumab
text:
Ianalumab is a monoclonal antibody that is being investigated for autoimmune hepatitis, multiple sclerosis, pemphigus vulgaris, rheumatoid arthritis, Sjögren syndrome, and systemic lupus erythematosus. This drug is being developed by Novartis. In 2021 ianalumab was undergoing Phase II/III trials. In June 2023 ianalumab was involved in 22 clinical trials, of which 3 were completed, 14 were ongoing, 1 was planned, and 4 were terminated.
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Ianalumab
date created:
date modified:
2023-07-14T17:00:25Z
main entity:
{"identifier":"Q60785567","url":"https://www.wikidata.org/entity/Q60785567"}
image:
fields total:
13
integrity:
14